Evidence map›Paper›PMID 31441336›Full record

ArticleJournal of diabetes science and technology2020

Patient Input for Design of a Decision Support Smartphone Application for Type 1 Diabetes.

Leah M Wilson, Nichole Tyler, Peter G Jacobs, Virginia Gabo, Brian Senf, Ravi Reddy, Jessica R Castle

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Digital Health Technology in Diabetes Management in the Asia-Pacific Region: A Narrative Review of the Current Scenario and Future Outlook.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Feature-Based Machine Learning Model for Real-Time Hypoglycemia Prediction.Journal of diabetes science and technology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leah M WilsonDepartment of Medicine, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0003-3634-481X
Nichole TylerDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Peter G JacobsDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0001-9897-4783
Virginia GaboDepartment of Medicine, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR, USA.
Brian SenfDepartment of Medicine, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR, USA.
Ravi ReddyDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Jessica R CastleDepartment of Medicine, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR, USA.

Funding

Improving glucose control with advanced technology designed for high risk patients with type 1 diabetesR01DK120367 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOBS, PETER G, WILSON, LEAH MEGAN · 2018 to 2021
$2.4M
NIDDK NIH HHS R01 DK120367
6 · The paper itself

Abstract

backgroundDecision support smartphone applications integrated with continuous glucose monitors may improve glycemic control in type 1 diabetes (T1D). We conducted a survey to understand trends and needs of potential users to inform the design of decision support technology.

methodsA 70-question survey was distributed October 2017 through May 2018 to adults aged 18-80 with T1D from a specialty clinic and T1D Exchange online health community (myglu.org). The survey responses were used to evaluate potential features of a diabetes decision support tool by Likert scale and open responses.

resultsThere were 1542 responses (mean age 46.1 years [SD 15.2], mean duration of diabetes 26.5 years [SD 15.8]). The majority (84.2%) have never used an app to manage diabetes; however, a large majority (77.8%) expressed interest in using a decision support app. The ability to predict and avoid hypoglycemia was the most important feature identified by a majority of the respondents, with 91% of respondents indicating the highest level of interest in these features. The task that respondents find most difficult was management of glucose during exercise (only 47% of participants were confident in glucose management during exercise). The respondents also highly desired features that help manage glucose during exercise (85% of respondents were interested). The responses identified integration and interoperability with peripheral devices/apps and customization of alerts as important. Responses from participants were generally consistent across stratified categories.

conclusionsThese results provide valuable insight into patient needs in decision support applications for management of T1D.

Indexed as

Decision Support TechniquesMobile ApplicationsPatient ParticipationSmartphoneAdultAttitude to ComputersBiomarkersBlood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Diffusion of InnovationFemaleHumansHypoglycemic AgentsInsulinMaleBiomarkersBlood GlucoseHypoglycemic AgentsInsulindecision supportmultiple daily injectionssmartphone appsurveytype 1 diabetes

Identifiers

PMID31441336
PMCPMC7645130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.